Kcentra 1,000 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FQJX2
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,432
Award facts
- Contract value 100% obligated
- $21,432.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $21,432 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 1,000 unit vials of Kcentra. The award, issued on January 29, 2026, with an ultimate completion date of February 20, 2026, contains no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499.99 billion contract awarded on November 13, 2025, that authorizes DLA to procure comprehensive pharmaceutical products and medical consumables for Department of Defense healthcare operations.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, with substantial recent contracting activity through the DLA's Medical Supply Chain division. The company's extensive product portfolio includes oncology treatments, immunosuppressants, biologics, vaccines, specialty pharmaceuticals, and emergency medications that support military healthcare facilities worldwide. As the sole performer on this delivery order with no identified subcontractors, DMS Pharmaceutical Group's selection reflects its demonstrated performance and capability to fulfill the specialized pharmaceutical requirements of the DoD medical system under the broader PPV-G GEN V acquisition strategy.
Quick answers
Who was awarded contract SPE2DR26FQJX2?
SPE2DR26FQJX2 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FQJX2 worth?
The government has obligated $21,432 on SPE2DR26FQJX2.
Is contract SPE2DR26FQJX2 an order under another contract?
Yes. SPE2DR26FQJX2 is a delivery order under SPE2DR25D9135, an indefinite delivery contract.
Was contract SPE2DR26FQJX2 competed?
The extent of competition for SPE2DR26FQJX2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award